Form 4: Enanta Pharma Officer Sells Shares for Tax Obligations
Insider Transaction Report
Enanta Pharmaceuticals' Vice President of Finance, Harry R. Trout III, reported the sale and forfeiture of common stock to cover tax withholding obligations related to restricted stock unit awards.
Summary
- Harry R. Trout III, Vice President, Finance (Principal Financial Officer) of Enanta Pharmaceuticals Inc. (ENTA), reported transactions involving common stock.
- On December 1, 2025, 105 shares of ENTA common stock were forfeited at a price of $14.12 per share. This forfeiture covered withholding taxes due from a restricted stock unit (RSU) award granted on November 19, 2021.
- On December 2, 2025, 380 shares of ENTA common stock were sold at a price of $13.96 per share. This sale covered withholding taxes due from an RSU award granted on November 27, 2024.
- The sale on December 2, 2025, was explicitly stated as a "sell to cover" transaction to satisfy tax withholding obligations and was not a discretionary transaction by the reporting person.
- Following these reported transactions, Harry R. Trout III beneficially owns 16,890 shares of common stock directly.
Sentiment
Score: 5
Explanation: The transactions reported are routine 'sell to cover' or forfeiture actions to satisfy tax obligations related to restricted stock unit awards, not indicative of discretionary selling or a change in sentiment by the insider.
Positives
- The transactions are related to the settlement of restricted stock unit awards, indicating prior compensation grants to the officer, which is a common form of executive incentive.
Negatives
- A total of 485 shares (105 forfeited and 380 sold) were disposed of by the officer, reducing their direct beneficial ownership.
Future Outlook
NA
Management Comments
- "The sale was to satisfy tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the reporting person."
Industry Context
NA
Stakeholder Impact
- Shareholders: Minimal impact, as these are routine tax-related transactions by an officer and not a discretionary sale indicating a change in confidence in the company's prospects.
- Employees: The RSU awards are part of executive compensation, which is a standard practice for attracting and retaining talent.
Key Dates
| Date | Description |
|---|---|
| 11/19/2021 | Grant date of a restricted stock unit award. |
| 11/27/2024 | Grant date of a restricted stock unit award. |
| 12/01/2025 | Date of forfeiture of 105 common shares for tax withholding. |
| 12/02/2025 | Date of sale of 380 common shares for tax withholding. |
| 12/03/2025 | Date the Form 4 was signed and filed. |
Keywords
Enanta Pharmaceuticals, ENTA, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Officer Stock Sale, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.